Intervention Review

Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants

  1. A. Semih Görk1,*,
  2. Richard A Ehrenkranz2,
  3. Michael B Bracken3

Editorial Group: Cochrane Neonatal Group

Published Online: 23 JAN 2008

Assessed as up-to-date: 14 JAN 2010

DOI: 10.1002/14651858.CD006071.pub2


How to Cite

Görk AS, Ehrenkranz RA, Bracken MB. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006071. DOI: 10.1002/14651858.CD006071.pub2.

Author Information

  1. 1

    Yale University, Department of Pediatrics, Division of Perinatal Medicine, New Haven, CT, USA

  2. 2

    Yale University, Department of Pediatrics, New Haven, Connecticut, USA

  3. 3

    Yale University Medical School, Department of Epidemiology & Public Health, New Haven, CT, USA

*A. Semih Görk, Department of Pediatrics, Division of Perinatal Medicine, Yale University, 333 Cedar St, PO Box 208064, New Haven, CT, 06520-8064, USA. semih.gork@yale.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH